111 related articles for article (PubMed ID: 11036198)
61. Effects of cyclosporin A, FK506 and rapamycin on calcineurin phosphatase activity in mouse brain.
Yu DY; Luo J; Bu F; Zhang W; Wei Q
IUBMB Life; 2006 Jul; 58(7):429-33. PubMed ID: 16801218
[TBL] [Abstract][Full Text] [Related]
62. Cyclosporin A promotes nuclear transfer of a cytoplasmic progesterone receptor mutant.
Jung-Testas I; Lebeau MC; Catelli MG; Baulieu EE
C R Acad Sci III; 1995 Aug; 318(8):873-8. PubMed ID: 7583777
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context.
Siemann G; Blume R; Grapentin D; Oetjen E; Schwaninger M; Knepel W
Mol Pharmacol; 1999 Jun; 55(6):1094-100. PubMed ID: 10347253
[TBL] [Abstract][Full Text] [Related]
64. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control.
Furuke K; Nakamura H; Hori T; Iwata S; Maekawa N; Inamoto T; Yamaoka Y; Yodoi J
Int Immunol; 1995 Jun; 7(6):985-93. PubMed ID: 7577807
[TBL] [Abstract][Full Text] [Related]
65. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
66. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
Teutsch M; Higer M; Wang D; Wortis HW
Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
[TBL] [Abstract][Full Text] [Related]
67. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.
Ko H; Hambly BD; Eris JM; Levidiotis V; Wyburn K; Wu H; Chadban SJ; Yin JL
Transpl Immunol; 2008 Nov; 20(1-2):99-105. PubMed ID: 18662782
[TBL] [Abstract][Full Text] [Related]
68. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
Harding MW; Galat A; Uehling DE; Schreiber SL
Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
[TBL] [Abstract][Full Text] [Related]
69. Leukocyte chemotactic activity of FKBP and inhibition by FK506.
Leiva MC; Lyttle CR
Biochem Biophys Res Commun; 1992 Jul; 186(2):1178-83. PubMed ID: 1379802
[TBL] [Abstract][Full Text] [Related]
70. Neural roles of immunophilins and their ligands.
Sabatini DM; Lai MM; Snyder SH
Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
[TBL] [Abstract][Full Text] [Related]
71. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
Sharkey J; Butcher SP
Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
[TBL] [Abstract][Full Text] [Related]
72. Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB.
Alexanian AR; Bamburg JR
FASEB J; 1999 Sep; 13(12):1611-20. PubMed ID: 10463953
[TBL] [Abstract][Full Text] [Related]
73. Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation.
Miyamoto S; Safer B
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):803-12. PubMed ID: 10585867
[TBL] [Abstract][Full Text] [Related]
74. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
Bierer BE
Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
[No Abstract] [Full Text] [Related]
75. Secreted cyclophilin A, a peptidylprolyl cis-trans isomerase, mediates matrix assembly of hensin, a protein implicated in epithelial differentiation.
Peng H; Vijayakumar S; Schiene-Fischer C; Li H; Purkerson JM; Malesevic M; Liebscher J; Al-Awqati Q; Schwartz GJ
J Biol Chem; 2009 Mar; 284(10):6465-75. PubMed ID: 19112104
[TBL] [Abstract][Full Text] [Related]
76. Effect of rapamycin in combination with calcineurin inhibitors, FK506 and cyclosporin, following arterial injury.
Waller JR; Metcalfe MS; Nicholson ML
Transplant Proc; 2002 Aug; 34(5):1481-3. PubMed ID: 12176449
[No Abstract] [Full Text] [Related]
77. Cyclosporine and tacrolimus alter renin-angiotesin system in mouse medullary-thick ascending limb cultured cells.
Wu M; Yu H; Yang C; Bens M; Huang C; Ko Y; Vandewalle A
Transplant Proc; 2001; 33(1-2):1078-9. PubMed ID: 11267198
[No Abstract] [Full Text] [Related]
78. Potentiation of mitogenesis in adult rat chromaffin cell cultures by immunosuppressive agent FK506.
Powers JF; Brachold JM; Schelling K; Tischler AS
Neurosci Lett; 2004 Feb; 356(1):5-8. PubMed ID: 14746888
[TBL] [Abstract][Full Text] [Related]
79. FK506 and rapamycin: differential sensitivity of human, baboon, cynomolgus monkey, dog and pig lymphocytes.
Metcalfe S; Svvennsen R; Calne RY
Transpl Int; 1992; 5 Suppl 1():S514-5. PubMed ID: 14621863
[TBL] [Abstract][Full Text] [Related]
80. Systematic investigation and comparison of US FDA-approved immunosuppressive drugs FK506, cyclosporine and rapamycin for neuromuscular regeneration following chronic nerve compression injury.
Degrugillier L; Prautsch KM; Schaefer DJ; Guzman R; Kalbermatten DF; Schären S; Madduri S
Regen Med; 2021 Nov; 16(11):989-1003. PubMed ID: 34633207
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
